ReviewArthritis research & therapy2021

Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis-a comprehensive review.

Paul Emery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.